SCRIBEAMERICA OUTPATIENT FINAL EXAM 2026/2027 ACTUAL
QUESTIONS WITH VERIFIED ANSWERS., Exams of Medicine
Comprehensive Assessment
Year: 2026-2027 | Question Count: 100 Questions | 100% VERIFIED
Introduction
The ScribeAmerica Outpatient Final Exam Comprehensive Assessment provides an advanced, rigorous
evaluation of core clinical documentation competencies, medical knowledge, and operational workflows
required for professional clinical medical scribes in ambulatory and outpatient healthcare settings.
Designed to prepare scribes for seamless integration into outpatient medical teams, this examination
systematically evaluates proficiency across eight core domains: Medical Terminology and Anatomy,
Electronic Health Record (EHR) Navigation and Documentation, Patient History and Review of Systems
(ROS), Physical Examination Documentation, Assessment and Plan Formulation, Outpatient Workflow
and Triage, Medical Ethics, HIPAA, and Compliance, and Scribe-Provider Communication and
Professionalism. Mastery of these critical domains ensures high clinical chart accuracy, regulatory and
billing compliance, enhanced provider efficiency, and exemplary clinical documentation execution
across primary care and medical subspecialties.
Question 1
According to American College of Cardiology and American Heart Association (ACC/AHA) clinical
guidelines, how is Stage 1 Hypertension defined, and what primary organ systems are at risk for
chronic end-organ damage from uncontrolled hypertension?
A. Diastolic blood pressure >= 110 mmHg only; causes damage exclusively to the tympanic
membrane
B. Systolic blood pressure >= 160 mmHg only; causes damage exclusively to the liver and
gallbladder
C. Systolic blood pressure 130–139 mmHg or diastolic blood pressure 80–89 mmHg; causes target
organ damage to the heart (CAD, HF, LVH), brain (CVA, TIA), kidneys (CKD, nephrosclerosis), and
eyes (retinopathy)
D. Systolic blood pressure 120–129 mmHg and diastolic < 80 mmHg; causes damage exclusively to
the skeletal muscles
Correct Answer: C. Systolic blood pressure 130–139 mmHg or diastolic blood pressure 80–89
mmHg; causes target organ damage to the heart (CAD, HF, LVH), brain (CVA, TIA), kidneys
(CKD, nephrosclerosis), and eyes (retinopathy)
Rationale: Under the ACC/AHA guidelines: Normal BP is < 120/< 80 mmHg; Elevated BP is 120–
129/< 80 mmHg; Stage 1 HTN is 130–139/80–89 mmHg; Stage 2 HTN is >= 140 or >= 90 mmHg.
Chronic sustained hypertension causes end-organ damage to four primary systems: cardiovascular
(myocardial infarction, heart failure, left ventricular hypertrophy), cerebrovascular (stroke,
transient ischemic attack), renal (chronic kidney disease, arterionephrosclerosis), and ocular
(hypertensive retinopathy).
,Question 2
A patient with hyperlipidemia (HLD) presents for routine follow-up. What laboratory test
constitutes the gold standard for monitoring lipid status, and what class of medications is the
established first-line pharmacological therapy for lowering low-density lipoprotein cholesterol
(LDL-C)?
A. Urinalysis with microscopy; Beta-lactam antibiotics (such as amoxicillin)
B. Fasting Lipid Panel (measuring Total Cholesterol, LDL, HDL, and Triglycerides); HMG-CoA
reductase inhibitors (Statins, such as atorvastatin and rosuvastatin)
C. Comprehensive Metabolic Panel (CMP); Proton pump inhibitors (such as omeprazole)
D. Complete Blood Count (CBC); Loop diuretics (such as furosemide)
Correct Answer: B. Fasting Lipid Panel (measuring Total Cholesterol, LDL, HDL, and
Triglycerides); HMG-CoA reductase inhibitors (Statins, such as atorvastatin and rosuvastatin)
Rationale: Hyperlipidemia is evaluated via a Fasting Lipid Panel assessing Total Cholesterol, LDL
('bad' atherogenic cholesterol), HDL ('good' cardioprotective cholesterol), and Triglycerides. HMG-
CoA reductase inhibitors (Statins, e.g., atorvastatin, rosuvastatin, simvastatin) are first-line agents
that competitively inhibit the rate-limiting enzyme in hepatic cholesterol synthesis, significantly
reducing cardiovascular morbidity and mortality.
Question 3
When documenting a clinical encounter for a patient with Type 2 Diabetes Mellitus (T2DM), what
diagnostic Hemoglobin A1c threshold confirms diabetes, and what are the classic microvascular vs.
macrovascular complications associated with chronic hyperglycemia?
A. Fasting glucose >= 100 mg/dL; microvascular complications include alopecia; macrovascular
complications include eczema
B. HbA1c >= 6.5%; microvascular complications include retinopathy, nephropathy, and peripheral
neuropathy; macrovascular complications include coronary artery disease (CAD), peripheral artery
disease (PAD), and cerebrovascular accident (CVA)
C. HbA1c >= 5.0%; microvascular complications include osteoporosis and osteoarthritis;
macrovascular complications include asthma
D. HbA1c >= 8.5%; microvascular complications include otitis media; macrovascular complications
include GERD
Correct Answer: B. HbA1c >= 6.5%; microvascular complications include retinopathy,
nephropathy, and peripheral neuropathy; macrovascular complications include coronary
artery disease (CAD), peripheral artery disease (PAD), and cerebrovascular accident (CVA)
Rationale: Per American Diabetes Association (ADA) criteria, diabetes is diagnosed by an HbA1c >=
6.5%, fasting plasma glucose >= 126 mg/dL, or 2-hour post-OGTT glucose >= 200 mg/dL. Chronic
hyperglycemia causes microvascular damage (capillary basement membrane thickening leading to
diabetic retinopathy, nephropathy, and neuropathy) and accelerates macrovascular atherosclerosis
(CAD, PAD, and ischemic stroke).
,Question 4
A patient's Past Surgical History (PSHx) documents a 'CABG x 3' performed five years ago. How
should the medical scribe accurately interpret this surgical history in the electronic health record?
A. Coronary Angioplasty with Balloon Guide performed three consecutive times
B. Catheter Ablation of the Gallbladder with three surgical incisions
C. Carotid Artery Balloon Grafting to relieve bilateral cerebral stenosis
D. Coronary Artery Bypass Graft involving three vessels, performed to revascularize ischemic
myocardium in severe multivessel coronary artery disease
Correct Answer: D. Coronary Artery Bypass Graft involving three vessels, performed to
revascularize ischemic myocardium in severe multivessel coronary artery disease
Rationale: CABG stands for Coronary Artery Bypass Graft. 'CABG x 3' indicates a triple bypass
surgery where surgical grafts (such as the internal mammary artery or saphenous vein) were
anastomosed to three occluded coronary arteries to bypass high-grade stenoses and restore
myocardial perfusion.
Question 5
How does Chronic Obstructive Pulmonary Disease (COPD) fundamentally differ from Asthma in
pathophysiology, clinical presentation, and diagnostic spirometry findings?
A. COPD is completely reversible with a single dose of albuterol; Asthma causes permanent alveolar
wall destruction
B. COPD is characterized by progressive, largely irreversible airflow obstruction (post-
bronchodilator FEV1/FVC < 0.70) primarily caused by chronic tobacco exposure; whereas Asthma
features reversible bronchospasm and airway hyperresponsiveness often associated with atopy and
allergic triggers
C. COPD is diagnosed by an elevated sweat chloride test; Asthma is diagnosed by high blood urea
nitrogen
D. COPD affects only pediatric patients under 5 years of age; Asthma occurs exclusively in elderly
adults
Correct Answer: B. COPD is characterized by progressive, largely irreversible airflow
obstruction (post-bronchodilator FEV1/FVC < 0.70) primarily caused by chronic tobacco
exposure; whereas Asthma features reversible bronchospasm and airway
hyperresponsiveness often associated with atopy and allergic triggers
Rationale: COPD encompasses emphysema (alveolar destruction and airspace enlargement) and
chronic bronchitis (mucus hypersecretion and productive cough for >= 3 months in 2 consecutive
years), resulting in fixed, non-reversible airflow limitation (post-bronchodilator FEV1/FVC < 0.70).
Asthma involves chronic airway inflammation with reversible bronchoconstriction, demonstrating
significant spirometric improvement (> 12% and 200 mL increase in FEV1) following inhaled
bronchodilator administration.
, Question 6
A patient with long-standing Gastroesophageal Reflux Disease (GERD) undergoes an
esophagogastroduodenoscopy (EGD) that reveals 'Barrett's Esophagus'. What pathophysiological
process does this finding represent, and why is long-term surveillance indicated?
A. Formation of esophageal varices secondary to severe portal hypertension
B. Acute bacterial infection of the gastric antrum requiring 14 days of intravenous vancomycin
C. Benign hypertrophy of the lower esophageal sphincter causing achalasia
D. Intestinal metaplasia where the normal stratified squamous epithelium of the distal esophagus is
replaced by columnar epithelium due to chronic acid exposure, carrying an increased risk of
esophageal adenocarcinoma
Correct Answer: D. Intestinal metaplasia where the normal stratified squamous epithelium of
the distal esophagus is replaced by columnar epithelium due to chronic acid exposure,
carrying an increased risk of esophageal adenocarcinoma
Rationale: Barrett's esophagus is a specialized metaplastic transformation where chronic
gastroesophageal acid reflux induces replacement of normal squamous epithelium with mucin-
secreting columnar epithelium in the distal esophagus. It is a premalignant lesion that predisposes
patients to esophageal adenocarcinoma, necessitating periodic endoscopic surveillance biopsies.
Question 7
When reviewing an outpatient Comprehensive Metabolic Panel (CMP) for a patient with Chronic
Kidney Disease (CKD), which laboratory values reflect worsening renal excretory function, and how
is CKD Stage 3 clinically defined?
A. Elevated serum troponin and BNP; CKD Stage 3 is defined as complete anuria requiring
hemodialysis
B. Decreased serum potassium and elevated alkaline phosphatase; CKD Stage 3 is defined as an
eGFR < 15 mL/min/1.73 m²
C. Elevated serum AST and ALT with normal bilirubin; CKD Stage 3 is defined as an eGFR > 90
mL/min/1.73 m²
D. Elevated Serum Creatinine and Blood Urea Nitrogen (BUN) with a decreased estimated
Glomerular Filtration Rate (eGFR); CKD Stage 3 is defined as an eGFR between 30 and 59
mL/min/1.73 m²
Correct Answer: D. Elevated Serum Creatinine and Blood Urea Nitrogen (BUN) with a
decreased estimated Glomerular Filtration Rate (eGFR); CKD Stage 3 is defined as an eGFR
between 30 and 59 mL/min/1.73 m²
Rationale: Renal excretory function is tracked using Serum Creatinine, BUN, and calculated eGFR.
CKD staging: Stage 1 (eGFR >= 90 with persistent albuminuria/kidney damage), Stage 2 (eGFR 60–
89), Stage 3a (eGFR 45–59), Stage 3b (eGFR 30–44), Stage 4 (eGFR 15–29, severe reduction), and
Stage 5 (eGFR < 15 or ESRD requiring renal replacement therapy).
QUESTIONS WITH VERIFIED ANSWERS., Exams of Medicine
Comprehensive Assessment
Year: 2026-2027 | Question Count: 100 Questions | 100% VERIFIED
Introduction
The ScribeAmerica Outpatient Final Exam Comprehensive Assessment provides an advanced, rigorous
evaluation of core clinical documentation competencies, medical knowledge, and operational workflows
required for professional clinical medical scribes in ambulatory and outpatient healthcare settings.
Designed to prepare scribes for seamless integration into outpatient medical teams, this examination
systematically evaluates proficiency across eight core domains: Medical Terminology and Anatomy,
Electronic Health Record (EHR) Navigation and Documentation, Patient History and Review of Systems
(ROS), Physical Examination Documentation, Assessment and Plan Formulation, Outpatient Workflow
and Triage, Medical Ethics, HIPAA, and Compliance, and Scribe-Provider Communication and
Professionalism. Mastery of these critical domains ensures high clinical chart accuracy, regulatory and
billing compliance, enhanced provider efficiency, and exemplary clinical documentation execution
across primary care and medical subspecialties.
Question 1
According to American College of Cardiology and American Heart Association (ACC/AHA) clinical
guidelines, how is Stage 1 Hypertension defined, and what primary organ systems are at risk for
chronic end-organ damage from uncontrolled hypertension?
A. Diastolic blood pressure >= 110 mmHg only; causes damage exclusively to the tympanic
membrane
B. Systolic blood pressure >= 160 mmHg only; causes damage exclusively to the liver and
gallbladder
C. Systolic blood pressure 130–139 mmHg or diastolic blood pressure 80–89 mmHg; causes target
organ damage to the heart (CAD, HF, LVH), brain (CVA, TIA), kidneys (CKD, nephrosclerosis), and
eyes (retinopathy)
D. Systolic blood pressure 120–129 mmHg and diastolic < 80 mmHg; causes damage exclusively to
the skeletal muscles
Correct Answer: C. Systolic blood pressure 130–139 mmHg or diastolic blood pressure 80–89
mmHg; causes target organ damage to the heart (CAD, HF, LVH), brain (CVA, TIA), kidneys
(CKD, nephrosclerosis), and eyes (retinopathy)
Rationale: Under the ACC/AHA guidelines: Normal BP is < 120/< 80 mmHg; Elevated BP is 120–
129/< 80 mmHg; Stage 1 HTN is 130–139/80–89 mmHg; Stage 2 HTN is >= 140 or >= 90 mmHg.
Chronic sustained hypertension causes end-organ damage to four primary systems: cardiovascular
(myocardial infarction, heart failure, left ventricular hypertrophy), cerebrovascular (stroke,
transient ischemic attack), renal (chronic kidney disease, arterionephrosclerosis), and ocular
(hypertensive retinopathy).
,Question 2
A patient with hyperlipidemia (HLD) presents for routine follow-up. What laboratory test
constitutes the gold standard for monitoring lipid status, and what class of medications is the
established first-line pharmacological therapy for lowering low-density lipoprotein cholesterol
(LDL-C)?
A. Urinalysis with microscopy; Beta-lactam antibiotics (such as amoxicillin)
B. Fasting Lipid Panel (measuring Total Cholesterol, LDL, HDL, and Triglycerides); HMG-CoA
reductase inhibitors (Statins, such as atorvastatin and rosuvastatin)
C. Comprehensive Metabolic Panel (CMP); Proton pump inhibitors (such as omeprazole)
D. Complete Blood Count (CBC); Loop diuretics (such as furosemide)
Correct Answer: B. Fasting Lipid Panel (measuring Total Cholesterol, LDL, HDL, and
Triglycerides); HMG-CoA reductase inhibitors (Statins, such as atorvastatin and rosuvastatin)
Rationale: Hyperlipidemia is evaluated via a Fasting Lipid Panel assessing Total Cholesterol, LDL
('bad' atherogenic cholesterol), HDL ('good' cardioprotective cholesterol), and Triglycerides. HMG-
CoA reductase inhibitors (Statins, e.g., atorvastatin, rosuvastatin, simvastatin) are first-line agents
that competitively inhibit the rate-limiting enzyme in hepatic cholesterol synthesis, significantly
reducing cardiovascular morbidity and mortality.
Question 3
When documenting a clinical encounter for a patient with Type 2 Diabetes Mellitus (T2DM), what
diagnostic Hemoglobin A1c threshold confirms diabetes, and what are the classic microvascular vs.
macrovascular complications associated with chronic hyperglycemia?
A. Fasting glucose >= 100 mg/dL; microvascular complications include alopecia; macrovascular
complications include eczema
B. HbA1c >= 6.5%; microvascular complications include retinopathy, nephropathy, and peripheral
neuropathy; macrovascular complications include coronary artery disease (CAD), peripheral artery
disease (PAD), and cerebrovascular accident (CVA)
C. HbA1c >= 5.0%; microvascular complications include osteoporosis and osteoarthritis;
macrovascular complications include asthma
D. HbA1c >= 8.5%; microvascular complications include otitis media; macrovascular complications
include GERD
Correct Answer: B. HbA1c >= 6.5%; microvascular complications include retinopathy,
nephropathy, and peripheral neuropathy; macrovascular complications include coronary
artery disease (CAD), peripheral artery disease (PAD), and cerebrovascular accident (CVA)
Rationale: Per American Diabetes Association (ADA) criteria, diabetes is diagnosed by an HbA1c >=
6.5%, fasting plasma glucose >= 126 mg/dL, or 2-hour post-OGTT glucose >= 200 mg/dL. Chronic
hyperglycemia causes microvascular damage (capillary basement membrane thickening leading to
diabetic retinopathy, nephropathy, and neuropathy) and accelerates macrovascular atherosclerosis
(CAD, PAD, and ischemic stroke).
,Question 4
A patient's Past Surgical History (PSHx) documents a 'CABG x 3' performed five years ago. How
should the medical scribe accurately interpret this surgical history in the electronic health record?
A. Coronary Angioplasty with Balloon Guide performed three consecutive times
B. Catheter Ablation of the Gallbladder with three surgical incisions
C. Carotid Artery Balloon Grafting to relieve bilateral cerebral stenosis
D. Coronary Artery Bypass Graft involving three vessels, performed to revascularize ischemic
myocardium in severe multivessel coronary artery disease
Correct Answer: D. Coronary Artery Bypass Graft involving three vessels, performed to
revascularize ischemic myocardium in severe multivessel coronary artery disease
Rationale: CABG stands for Coronary Artery Bypass Graft. 'CABG x 3' indicates a triple bypass
surgery where surgical grafts (such as the internal mammary artery or saphenous vein) were
anastomosed to three occluded coronary arteries to bypass high-grade stenoses and restore
myocardial perfusion.
Question 5
How does Chronic Obstructive Pulmonary Disease (COPD) fundamentally differ from Asthma in
pathophysiology, clinical presentation, and diagnostic spirometry findings?
A. COPD is completely reversible with a single dose of albuterol; Asthma causes permanent alveolar
wall destruction
B. COPD is characterized by progressive, largely irreversible airflow obstruction (post-
bronchodilator FEV1/FVC < 0.70) primarily caused by chronic tobacco exposure; whereas Asthma
features reversible bronchospasm and airway hyperresponsiveness often associated with atopy and
allergic triggers
C. COPD is diagnosed by an elevated sweat chloride test; Asthma is diagnosed by high blood urea
nitrogen
D. COPD affects only pediatric patients under 5 years of age; Asthma occurs exclusively in elderly
adults
Correct Answer: B. COPD is characterized by progressive, largely irreversible airflow
obstruction (post-bronchodilator FEV1/FVC < 0.70) primarily caused by chronic tobacco
exposure; whereas Asthma features reversible bronchospasm and airway
hyperresponsiveness often associated with atopy and allergic triggers
Rationale: COPD encompasses emphysema (alveolar destruction and airspace enlargement) and
chronic bronchitis (mucus hypersecretion and productive cough for >= 3 months in 2 consecutive
years), resulting in fixed, non-reversible airflow limitation (post-bronchodilator FEV1/FVC < 0.70).
Asthma involves chronic airway inflammation with reversible bronchoconstriction, demonstrating
significant spirometric improvement (> 12% and 200 mL increase in FEV1) following inhaled
bronchodilator administration.
, Question 6
A patient with long-standing Gastroesophageal Reflux Disease (GERD) undergoes an
esophagogastroduodenoscopy (EGD) that reveals 'Barrett's Esophagus'. What pathophysiological
process does this finding represent, and why is long-term surveillance indicated?
A. Formation of esophageal varices secondary to severe portal hypertension
B. Acute bacterial infection of the gastric antrum requiring 14 days of intravenous vancomycin
C. Benign hypertrophy of the lower esophageal sphincter causing achalasia
D. Intestinal metaplasia where the normal stratified squamous epithelium of the distal esophagus is
replaced by columnar epithelium due to chronic acid exposure, carrying an increased risk of
esophageal adenocarcinoma
Correct Answer: D. Intestinal metaplasia where the normal stratified squamous epithelium of
the distal esophagus is replaced by columnar epithelium due to chronic acid exposure,
carrying an increased risk of esophageal adenocarcinoma
Rationale: Barrett's esophagus is a specialized metaplastic transformation where chronic
gastroesophageal acid reflux induces replacement of normal squamous epithelium with mucin-
secreting columnar epithelium in the distal esophagus. It is a premalignant lesion that predisposes
patients to esophageal adenocarcinoma, necessitating periodic endoscopic surveillance biopsies.
Question 7
When reviewing an outpatient Comprehensive Metabolic Panel (CMP) for a patient with Chronic
Kidney Disease (CKD), which laboratory values reflect worsening renal excretory function, and how
is CKD Stage 3 clinically defined?
A. Elevated serum troponin and BNP; CKD Stage 3 is defined as complete anuria requiring
hemodialysis
B. Decreased serum potassium and elevated alkaline phosphatase; CKD Stage 3 is defined as an
eGFR < 15 mL/min/1.73 m²
C. Elevated serum AST and ALT with normal bilirubin; CKD Stage 3 is defined as an eGFR > 90
mL/min/1.73 m²
D. Elevated Serum Creatinine and Blood Urea Nitrogen (BUN) with a decreased estimated
Glomerular Filtration Rate (eGFR); CKD Stage 3 is defined as an eGFR between 30 and 59
mL/min/1.73 m²
Correct Answer: D. Elevated Serum Creatinine and Blood Urea Nitrogen (BUN) with a
decreased estimated Glomerular Filtration Rate (eGFR); CKD Stage 3 is defined as an eGFR
between 30 and 59 mL/min/1.73 m²
Rationale: Renal excretory function is tracked using Serum Creatinine, BUN, and calculated eGFR.
CKD staging: Stage 1 (eGFR >= 90 with persistent albuminuria/kidney damage), Stage 2 (eGFR 60–
89), Stage 3a (eGFR 45–59), Stage 3b (eGFR 30–44), Stage 4 (eGFR 15–29, severe reduction), and
Stage 5 (eGFR < 15 or ESRD requiring renal replacement therapy).
